[Method for obtaining reagents for identifying HLA system antigens]. 1984

V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
February 1982, Archives of pathology & laboratory medicine,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
January 1982, Akusherstvo i ginekologiia,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
May 1978, Transplantation,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
January 1981, Sangre,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
January 1990, Terapevticheskii arkhiv,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
June 1983, Fysiatricky a reumatologicky vestnik,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
January 1984, Medicinski pregled,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
October 1982, Human immunology,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
June 2010, Oncotarget,
V I Levin, and G V Semenov, and T P Naumova, and A T Tananov, and R M Kut'ina
January 2020, PloS one,
Copied contents to your clipboard!